HCA661 peptides H110 and H246 are naturally processed in dendritic cells (DCs) and when applied to DCs, they are sufficient to induce autologous CD8+ T cells to initiate cytotoxic responses against HCA661(+) human cancer cells. Here, TFDP3 is linked to cancer.